Type 1 diabetes
Type 1 diabetes is a chronic autoimmune disease characterised by insulin deficiency and
resultant hyperglycaemia. Knowledge of type 1 diabetes has rapidly increased over the past …
resultant hyperglycaemia. Knowledge of type 1 diabetes has rapidly increased over the past …
[HTML][HTML] A global perspective on the issue of access to insulin
The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A
century later, availability and affordability of insulin remain a challenge in many parts of the …
century later, availability and affordability of insulin remain a challenge in many parts of the …
A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison
OBJECTIVE As diabetes technology use in youth increases worldwide, inequalities in
access may exacerbate disparities in hemoglobin A1c (HbA1c). We hypothesized that an …
access may exacerbate disparities in hemoglobin A1c (HbA1c). We hypothesized that an …
Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
Background The amount of insulin needed to effectively treat type 2 diabetes worldwide is
unknown. It also remains unclear how alternative treatment algorithms would affect insulin …
unknown. It also remains unclear how alternative treatment algorithms would affect insulin …
[图书][B] The economics of health and health care
The Economics of Health and Health Care is the market-leading health economics textbook,
providing comprehensive coverage of all the key topics, and balancing economic theory …
providing comprehensive coverage of all the key topics, and balancing economic theory …
Diabetes in sub-Saharan Africa–from policy to practice to progress: targeting the existing gaps for future care for diabetes
SD Pastakia, CR Pekny, SM Manyara… - … syndrome and obesity …, 2017 - Taylor & Francis
The global prevalence and impact of diabetes has increased dramatically, particularly in sub-
Saharan Africa. This region faces unique challenges in combating the disease including …
Saharan Africa. This region faces unique challenges in combating the disease including …
Constraints and challenges in access to insulin: a global perspective
D Beran, M Ewen, R Laing - The lancet Diabetes & endocrinology, 2016 - thelancet.com
Substantial attention has been given to the issue of access to medicines for communicable
diseases; however, access to essential medicines for diabetes, especially insulin, has had …
diseases; however, access to essential medicines for diabetes, especially insulin, has had …
Comparing generic drug markets in Europe and the United States: prices, volumes, and spending
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …
drug markets in Europe and the United States. Regulators should make it easier for generic …
Estimated minimum prices and lowest available national prices for antiobesity medications: improving affordability and access to treatment
J Levi, J Wang, F Venter, A Hill - Obesity, 2023 - Wiley Online Library
Objective Novel antiobesity treatments are highly effective in recent clinical trials. Access to
these medications is needed to supplement lifestyle and surgical interventions for millions …
these medications is needed to supplement lifestyle and surgical interventions for millions …
Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013
Methods| We analyzed individual and prescription-level data from the Medical Expenditure
Panel Survey (MEPS) to describe and compare trends in expenditure and price of …
Panel Survey (MEPS) to describe and compare trends in expenditure and price of …